U.S. flag

An official website of the United States government

Filters

See more specimen types...
See more states

Other countries

See more countries

Results: 1 to 20 of 253

Tests names and labsConditionsGenes, analytes, and microbesMethods

Lung cancer, protection against, 211980, Autosomal recessive (CASP8 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, 211980, Autosomal recessive (Squamous cell carcinoma of esophagus) (DLEC1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, 211980, Autosomal recessive (PPP2R1B gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, 211980, Autosomal recessive (RASSF1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, somatic, 211980 (KRAS gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, susceptibility to, 211980, Autosomal recessive (ERCC6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, resistance to, 211980, Autosomal recessive (MLPA)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • D Deletion/duplication analysis

Lung cancer, somatic, 211980 (MAP3K8 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, resistance to, 211980, Autosomal recessive (CYP2A6 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, susceptibility to, 211980, Autosomal recessive (FASLG gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Lung cancer, somatic, 211980 (SLC22A18 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Nonsmall cell lung cancer, response to tyrosine kinase inhibitor in, 211980, Autosomal recessive (EGFR gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Nonsmall cell lung cancer, susceptibility to, 211980, Autosomal recessive (EGFR gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Nonsmall cell lung cancer, somatic, 211980 (IRF1 gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Adenocarcinoma of lung, somatic, 211980 (BRAF V600E - 599 ve 601. codons mutations - Exon 15 mutations) (BRAF gene) (Sequence Analysis) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • E Sequence analysis of select exons

Adenocarcinoma of lung, somatic, 211980 (PRKN gene) (Sequence Analysis-All Coding Exons) (Postnatal)

Intergen Intergen Genetics and Rare Diseases Diagnosis Center
Turkey
11
  • C Sequence analysis of the entire coding region

Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes)

Genesys Diagnostics Genesys Diagnostics, Inc.
United States
10999
  • X Mutation scanning of select exons

Lung Cancer Driver Profile

GoPath Diagnostics
United States
13
  • I Immunohistochemistry
  • F Fluorescence in situ hybridization (FISH)
  • D Deletion/duplication analysis

KRAS Mutation Analysis

PathGroup
United States
131
  • T Targeted variant analysis

EGFR targeted variants

CIBIC S.A.
Argentina
21
  • T Targeted variant analysis

Results: 1 to 20 of 253

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.